Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Hester Biosciences Limited ( (IN:HESTERBIO) ) has provided an update.
Hester Biosciences Limited has announced the appointment of Mr. Ashish Desai as the new Chief Financial Officer, effective from November 20, 2025. Mr. Desai, who brings over 25 years of experience in finance and accounting, will transition from his current role as Group Finance Controller. This strategic appointment is expected to enhance the company’s financial management and strengthen its market position, given Mr. Desai’s extensive background in financial restructuring and cost optimization.
More about Hester Biosciences Limited
Hester Biosciences Limited operates in the biotechnology industry, focusing on the production of vaccines and other biological products. The company is known for its contributions to animal healthcare and has a significant market presence in the veterinary sector.
Average Trading Volume: 487
Technical Sentiment Signal: Sell
Current Market Cap: 14.17B INR
For detailed information about HESTERBIO stock, go to TipRanks’ Stock Analysis page.